Hearing:
“Improving Drug Pricing Transparency and Lowering Prices for American Consumers”
Subcommittee on Health (Committee on Energy and Commerce)
Tuesday, May 21, 2019 (10:30 AM - 12:30 PM)
2123 RHOB
Washington, D.C.
Witnesses
Ms. Lisa Joldersma
Senior Vice President, Insurance and State Issues, Pharmaceutical Research and Manufactures of America
Added
05/18/2019 at 11:41 PM
- Written Testimony
[PDF]
Added
05/18/2019 at 11:41 PM
- Witness Biography
[PDF]
Added
05/18/2019 at 11:41 PM
Ms. Kristin Bass
Chief Policy and External Affairs Officer, Pharmaceutical Care Management Association
Added
05/18/2019 at 11:41 PM
- Written Testimony
[PDF]
Added
05/18/2019 at 11:57 PM
- Witness Biography
[PDF]
Added
05/18/2019 at 11:57 PM
Dr. Madelaine A. Feldman M.D. FACR
President, Coalition of State Rheumatology Organizations, Alliance of Specialty Medicine
Added
05/18/2019 at 11:41 PM
- Written Testimony
[PDF]
Added
05/18/2019 at 11:41 PM
- Witness Biography
[PDF]
Added
05/18/2019 at 11:41 PM
Mr. Frederick Isasi
Executive Director, Families USA
Added
05/18/2019 at 11:41 PM
- Written Testimony
[PDF]
Added
05/18/2019 at 11:41 PM
- Witness Biography
[PDF]
Added
05/18/2019 at 11:41 PM
Mr. Mark Miller
Executive Vice President of Health Care, Arnold Ventures
Added
05/18/2019 at 11:41 PM
Dr. Douglas Holtz-Eakin
President, American Action Forum
Added
05/18/2019 at 11:41 PM
- Written Testimony
[PDF]
Added
05/18/2019 at 11:41 PM
- Witness Biography
[PDF]
Added
05/18/2019 at 11:41 PM
Text of Legislation
- H.R. 2069, the "Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act of the "SPIKE Act" (Horsford)
[PDF]
Added
05/17/2019 at 03:37 PM
- H.R. 2115, the "Public Disclosure of Drug Discounts Act" (Spanberger)
[PDF]
Added
05/17/2019 at 03:37 PM
- H.R. 2064, a bill to amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes (Chu)
[PDF]
Added
05/17/2019 at 03:37 PM
- H.R. 2087, the "Drug Price Transparency Act" (Doggett)
[PDF]
Added
05/17/2019 at 03:37 PM
- H.R. 2296,the "Fair Accountability and Innovative Research Drug Pricing Act", or the “FAIR Drug Pricing Act” (Schakowsky)
[PDF]
Added
05/17/2019 at 03:37 PM
- H.R. 2376,the "Prescription Pricing for the People Act of 2019" (Collins)
[PDF]
Added
05/17/2019 at 03:37 PM
- H.R. 2757, the "Creating Lower cost Alternatives for Your prescription drugs Act"
[PDF]
Added
05/17/2019 at 06:16 PM
Support Documents
- Hearing Notice
[PDF]
- Hearing Memo
[PDF]
Added
05/17/2019 at 05:27 PM
- Document for the Record - Letter from the American Society of Clinical Oncology regarding H.R. 2296, H.R. 2087, and H.R. 2064
[PDF]
Added
09/29/2022 at 12:41 PM
- Document for the Record - Letter from The Campaign for Sustainable Rx Pricing in Support of H.R. 2296, H.R. 2069, H.R. 2087, H.R. 2064, and H.R. 2757
[PDF]
Added
09/29/2022 at 12:41 PM
- Document for the Record - Letter from AARP in Support of H.R. 2296, H.R. 2069, H.R. 2087, H.R. 2115, and H.R. 2064
[PDF]
Added
09/29/2022 at 12:41 PM
- Document for the Record - Letter from the National Multiple Sclerosis Society
[PDF]
Added
09/29/2022 at 12:41 PM
- Document for the Record - Letter from the Alliance of Specialty Medicine regarding H.R. 2113
[PDF]
Added
09/29/2022 at 12:41 PM
Member Statements
- Opening Statement of Rep. Anna G. Eshoo, Chairwoman of the Subcommittee on Health
[PDF]
Added
09/29/2022 at 12:41 PM
- Opening Statement of Rep. Greg Walden, Ranking Member of the Full Committee
[PDF]
Added
09/29/2022 at 12:41 PM
- Opening Statement of Rep. Michael C. Burgess, Ranking Member of the Subcommittee on Health
[PDF]
Added
09/29/2022 at 12:41 PM
- Opening Statement of Rep. Eliot L. Engel
[PDF]
Added
09/29/2022 at 12:41 PM
- Opening Statement of Rep. Janice D. Schakowsky
[PDF]
Added
09/29/2022 at 12:41 PM
Hearing Record
- Preliminary Unedited Hearing Transcript
[PDF]
Added
10/09/2020 at 01:17 PM
First Published:
May 16, 2019 at 07:33 PM
Last Updated:
September 29, 2022 at 12:49 PM